Senores Pharmaceuticals Limited has announced the closure of its trading window for trading in the company's securities by Directors, Promoters, Designated Persons, and their immediate relatives. The trading window will be closed from 1 Apr 25 and will remain closed until 48 hours after the announcement of the audited financial results for the quarter and financial year ending 31 Mar 25. The date of the Board Meeting for approving the audited financial results will be intimated separately.